This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BioProcess International: COVID-19 Therapeutic Development & Production
April 27-28, 2025
Delivered in a 100% Virtual FormatEastern Daylight Time (EST)

David K. Robinson, Ph.D.
Deputy Director, CMC Vaccines Development & Surveillance at Bill and Melinda Gates Foundation
Speaker

Profile

As Deputy Director, CMC Vaccines Development and Surveillance, David and his team work with internal and external partners to develop manufacturing technologies and execute CMC strategies to advance the foundation’s goal to save lives and reduce healthcare inequities. Specifically for COVID, David is a co-chair of the COVAX Vaccine Manufacturing SWAT team. David received his Bachelor’s degree from the University of California, Berkeley, and his Doctorate from the Massachusetts Institute of Technology, both in chemical engineering. David did his post-doctoral studies at the ETH in Zurich. David previously spent 25 years at Merck & Co, Inc (MSD), holding VP positions as head of Bioprocess R&D, Biologics Project Leadership and CMC Regulatory.

Agenda Sessions

  • Afternoon Keynote: An Impressive, but not Perfect, Global Response to the Pandemic

    16:50